Skip to main content
Premium Trial:

Request an Annual Quote

Test of the China Initiative

Science writes that the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

That program aimed to sniff out instance of economic espionage and research theft in the US by China, but as Science notes, most of nearly two dozen researchers ensnared by the initiative's investigations were not charged with espionage or intellectual property theft. Lieber, for instance, was charged in January 2020 with making false claims about funding he received from China's Thousand Talents Program. Similarly, Anming Hu, a nanotechnology researcher whose case was the first to go to court, was charged with wire fraud and making false statements — charges of which he was acquitted.

Lieber, who has pleaded not guilty, is the next researcher whose case is to head to trial according to Science. It adds that court watchers are wondering how the trial will play out amid increasing calls for the China Initiative to be curbed or even eliminated. Science adds that critics have argued that the errors uncovered in most of the cases should lead to civil or administrative penalties.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.